DEBORAH ALDRIDGE: Open Payments
NPI 1104830652 · OLATHE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$335 in 19 payments from 10 companies in 2025. Trend: 2023 $273 · 2024 $379 · 2025 $335
Food & beverage: $335
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $69 |
| Novo Nordisk Inc | 4 | $60 |
| PFIZER INC. | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| IBSA Pharma Inc. | 1 | $24 |
| Boston Scientific Corporation | 1 | $24 |
| Lilly USA, LLC | 1 | $20 |
| Abbott Laboratories | 1 | $19 |
| Noven Therapeutics, LLC | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: QULIPTA, Ozempic, PREVNAR 20, Tirosint, WATCHMAN FLX, FREESTYLE LIBRE 3, Xelstrym, ELIQUIS.
Industry payments across KS — which companies pay providers there.
